Do you want to read an article? Please log in or register.
Framework for the evaluation of new tests for tuberculosis infection
Tuberculosis
RECOMMENDED
Related content
RECOMMENDED
TuberculosisFurther Publications
Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study
Lancet Infect Dis.
Berrocal-Almanza LC, Harris R, Lalor MK, Muzyamba MC, Were J, O'Connell AM, Mirza A, Kon OM, Lalvani A, Zenner D
doi: 10.1016/S1473-3099(19)30260-9.
RECOMMENDED
Tuberculosis
Tests for tuberculosis infection: landscape analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Hamada Y, Cirillo DM, Matteelli A, Penn-Nicholson A, Rangaka MX, Ruhwald M
doi: 10.1183/13993003.00167-2021
RECOMMENDED
Tuberculosis
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study
Lancet Infect Dis.
Whitworth HS, Badhan A, Boakye AA, Takwoingi Y, Rees-Roberts M, Partlett C, Lambie H, Innes J, Cooke G, Lipman M, Conlon C, Macallan D, Chua F, Post FA, Wiselka M, Woltmann G, Deeks JJ, Kon OM, Lalvani A; Interferon-γ Release Assays for Diagnostic Evaluation of Active Tuberculosis study group
doi: 10.1016/S1473-
Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease
PLoS One.
La Manna MP, Orlando V, Li Donni P, Sireci G, Di Carlo P, Cascio A, Dieli F, Caccamo N
doi: 10.1371/
Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis
N Engl J Med.
Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, Yuan X, Mo X, Zhu H, Xu P, Gao Q, Lee M, Lee J, Smith LE, Chen RY, Joh JS, Cho Y, Liu X, Ruan X1, Liang L, Dharan N, Cho SN, Barry CE 3rd, Ellner JJ, Dorman SE, Alland D
doi: 10.1056/
COMMENTED
Tuberculosis
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study
Lancet Infect Dis.
Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Lynn W, Burgess H, Mann B, Imran A, Sridhar S, Tsou CY, Nikolayevskyy V, Rees-Roberts M, Whitworth H, Kon OM, Haldar P, Kunst H, Anderson S, Hayward A, Watson JM, Milburn H, Lalvani A; PREDICT Study Team
doi: 10.1016/
COMMENTED
Tuberculosis
Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
N Engl J Med.
Blanc FX, Badje AD, Bonnet M, Gabillard D, Messou E, Muzoora C, Samreth S, Nguyen BD, Borand L, Domergue A, Rapoud D, Natukunda N, Thai S, Juchet S, Eholié SP, Lawn SD, Domoua SK, Anglaret X, Laureillard D, STATIS ANRS 12290 Trial Team.
doi: 10.1056/NEJMoa1910708.
RECOMMENDED
Tuberculosis
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Infect Dis.
Campbell JR, Trajman A, Cook VJ, Johnston JC, Adjobimey M, Ruslami R, Eisenbeis L, Fregonese F, Valiquette C, Benedetti A, Menzies D
doi: 10.1016/S1473-3099(19)30575-4.
RECOMMENDED
Tuberculosis
Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Glob Health.
Yuen CM, Seddon JA, Keshavjee S, Dodd PJ
doi: 10.1016/S2214-109X(20)30075-9.